Write To Karl Loren About This Page
Mention of EDTA and NAC as handling MMPs
|
|
|
|
(advertisement)
|
Background: A corneal ulcer is defined as a lesion that involves degradation of the corneal stroma. This condition is associated with inflammation, either sterile or infectious. The primary purpose of this article is to highlight the pathogenesis of noninfectious stromal ulceration. The immune mechanisms of autoimmune ulcerative keratitis, particularly peripheral, are not included within this article.
Pathophysiology: An understanding of the pathophysiology of sterile corneal ulceration requires a review of the processes involved in epithelial and stromal wound healing, as well as an examination of the role of precorneal tear film, corneal nerves, proteolytic enzymes, and cytokines. Epithelial wound healing Corneal ulceration always begins with an epithelial defect. A persistent epithelial defect allows the corneal stroma to be exposed to the external environment and permits the process of stromal degradation. Epithelial cell migration occurs centripetally until a defect is covered completely. Epithelial cells adjacent to the area of the defect flatten, lose their hemidesmosome attachments, and migrate on transient focal contact zones that are formed between cytoplasmic actin filaments and extracellular matrix proteins. Vinculin, integrin, fibronectin, fibrinogen, and fibrin are found in the region of these contact zones, which are formed continuously and cleaved to allow for cell migration. Plasmin is the protease responsible for cleaving fibrinogen and fibrin at these focal contact zones. The basement membrane is also important for epithelial migration, and abnormalities in basement membrane structure, whether due to trauma (eg, recurrent erosion syndrome) or dystrophy (eg, basement membrane dystrophy), can lead to persistence of corneal epithelial defects and stromal ulceration. A sufficient supply of progenitor stem cells to facilitate epithelial cell proliferation is important for the cornea. A deficiency of limbal stem cells, either from disease (eg, aniridia) or trauma (eg, chemical burn), can preclude adequate epithelial wound healing, resulting in a persistent epithelial defect and allowing for stromal ulceration. Limbal stem cell transplantation (autograft, allograft, or ex vivo expansion) may be necessary in these cases. Stromal wound healing Stromal wound healing occurs via stromal keratocyte migration, proliferation, and deposition of extracellular matrix molecules, including collagen (specifically type III), adhesion proteins (eg, fibronectin, laminin), and glycosaminoglycans. These processes are facilitated by a phenotypic change among quiescent keratocytes to become active myofibroblasts, a task mediated by transforming growth factor beta (of presumptive epithelial origin). Stromal necrosis and degradation Matrix metalloproteinases (MMPs) are a group of structurally related endopeptidases that require a metal cofactor. To date, 20 such enzymes have been identified and are categorized according to their substrate specificity. The main function of metalloproteinases is to degrade extracellular matrix and basement membrane components. With respect to corneal wound healing and ulceration, MMP-1, MMP-2, MMP-8, and MMP-9 appear to be the most important. MMP-2 and MMP-9 are known as gelatinases and are involved in cleaving collagen types IV, V, VII, and X, as well as fibronectin, laminin, elastin, and gelatins. MMP-1 and MMP-8 are involved in cleaving collagen types I, II, and III. Metalloproteinases are secreted as proenzymes by neutrophils, injured epithelial cells, and keratocytes. They are activated by proteolytic cleavage of the N-terminal region in the extracellular compartment. In vivo, tissue inhibitors of metalloproteinases (TIMPs) inhibit collagenase activity. MMP-9 is expressed by basal (replicating) epithelium and is thought to be important in the degradation of the basement lamina. In chemical injuries, this step always precedes the degradation of stromal extracellular matrix by MMP-1 and MMP-8. The collagenolytic activity of these latter enzymes reach a nadir of activity at approximately 3 weeks following injury, a time frame that parallels the peak of collagen synthesis activity in an alkali burn animal model. A relatively higher degree of collagenolysis relative to synthesis is thought to result in degradation, progressive corneal thinning, and, hence, ulceration of the corneal stroma. In vivo, this balance is moderated by cytokines secreted by the epithelium, stromal keratocytes, and inflammatory cells. Since all metalloproteinase enzymes require metal cofactors Ca2+ and Zn2+, such chelating agents as ethylenediaminetetraacetic acid (EDTA), acetylcysteine, and penicillamine inhibit collagenase activity. Tetracyclines also possess anticollagenolytic activity. Endogenous TIMPs and alpha2-macroglobulin have metalloproteinase inhibitory activity and are probably the main inhibitors of MMPs in vivo. The role of corneal nerves The cornea is densely innervated by fibers of the ophthalmic division of the trigeminal nerve and sympathetic nerve fibers from the superior cervical ganglion. The corneal epithelium is supplied by approximately 1000 small axons. Decreased corneal sensation from denervation can result in stromal ulceration and perforation. A decrease in tearing, protective reflexes, and blink rate are associated with decreased corneal sensation. In 1954, the classic experiment by Sigelman et al demonstrated that ocular surface changes associated with neurotropic keratitis in denervated animals persist despite tarsorrhaphy, suggesting a trophic effect of corneal nerves. The exact mechanism of this trophic effect is not definitively known. Evidence suggests that sensory neuron loss leads to a severe depletion of acetylcholine in an otherwise acetylcholine rich tissue, resulting in a relative decrease in epithelial cell growth. Other studies attributed the depletion of substance P associated with sensory denervation as the cause of the changes associated with neurotrophic keratitis. Recent clinical trials of nerve growth factor (NGF) by Bonini et al demonstrated a beneficial effect in promoting corneal epithelial wound healing and possibly improving sensitivity in patients with neurotrophic keratitis. The role of the precorneal tear film in ulceration The exposure of the bare corneal stroma to its environment secondary to deficient or impaired epithelial wound healing is thought to contribute to stromal degradation through environmental factors, cytokines, lytic enzymes, and neutrophils in the tear film. Direct neutrophil adhesion to the corneal stroma theoretically allows hydrolytic and collagenolytic enzymes, including MMP-8 (neutrophil collagenase), to contribute to the degradation of the corneal stromal extracellular matrix. Dohlman et al and subsequently Kenyon et al demonstrated that a glued on methylacrylate lens applied to a rabbit alkali burn model of corneal ulceration protected the stroma from collagenolysis by neutrophils and injured epithelial cells. Keratocyte fibroblasts also may contribute to this milieu. The prevention of neutrophil infiltration and promotion of epithelialization is thought to be at least one of the mechanisms responsible for the beneficial effect of amniotic membrane graft use in preventing stromal ulceration. In addition, cytokines, such as hepatocyte growth factor (HGF), keratocyte growth factor (KGF), and epidermal growth factor (EGF), are produced by the lacrimal gland and, thus, are present in tears. HGF is upregulated in response to corneal injury in parallel with increased aqueous tear production. In the wounded cornea, these cytokines may play an important role in regulating epithelial healing. Inflammatory cytokines, including interleukin 1 (IL-1) alpha, are detectable in normal human tears and may be important in causing further degradation of the corneal stroma either directly by inducing keratocyte apoptosis or by recruiting inflammatory cells via their chemotactic properties. In addition, an irregular tear film and a decreased tear film breakup time over the area of the bare stroma can cause a delle effect that may contribute to an unfavorable cellular environment for the viability and proliferation of stromal keratocytes. The role of cytokines The complex autocrine and paracrine functions of the cytokines involved in the interactions between the corneal epithelium and stromal keratocytes are important in achieving the appropriate responses to corneal wound healing. These responses are orchestrated by complex interactions between the cytokines secreted by each of these cell types. While their precise triggers and interactions are still being elucidated, cytokines can induce and mediate many of the fundamental steps involved in wound healing. Epithelial cell migration, proliferation, and differentiation are influenced by the stromal keratocyte cytokines, KGF and HGF. The cornea is not unique with respect to the stromal-epithelial interactions of these 2 cytokines, which are mediators of similar interactions in the breast, skin, and lung. Although the expression profiles of these cytokines lend themselves toward a linear interpretation of their stromal-epithelial interactions, these cytokines clearly are modulated further in vivo by the effects of other cytokines and truncated receptors of these molecules. In what is likely to be merely the tip of the iceberg with respect to the understanding of cytokine-cytokine interactions, both KGF and HGF mRNA production are altered by the fibroblast cytokines, EGF, transforming growth factor alpha, platelet-derived growth factor (PDGF), and IL-1. In addition, EGF, PDGF, IL-1 alpha, interleukin 6 (IL-6), and tumor necrosis factor (TNF) at low concentrations appear to enhance fibronectin (FN)-induced epithelial cell migration. Not to be eclipsed by stromal influences, epithelial cells modulate important keratocyte responses to epithelial cell injury. Keratocyte wound healing processes, including MMP production and regulation, HGF and KGF production, and keratocyte apoptosis, are mediated via various cytokines, including IL-1 and soluble Fas ligand. Anterior stromal keratocyte cell death is an important feature of corneal wounding and stromal degradation. Beyond keratocyte cell death caused by mechanical injury or necrosis associated with neutrophil infiltration, IL-1– and Fas ligand–mediated apoptosis is an important stromal response to epithelial injury. Since both of these cytokines can be produced by keratocytes, autocrine modulation of these responses may occur. IL-1 and PDGF also regulate MMP expression in stromal keratocytes. The exact keratocyte response to IL-1 is likely to be determined by the cytokine milieu in which the targeted keratocyte resides. Other cytokine systems that have demonstrated fibroblast apoptosis include TNF and bone morphogenic protein (BMP). Meticulous control of these cytokines conceivably allows for more predictable corneal wound healing. Topical KGF has been shown to accelerate epithelial wound healing in a rabbit model of corneal ulceration. Since its effects are mediated through a paracrine pathway, topical use of cytokines (eg, KGF) may prove to be especially effective in ocular disorders accompanied by loss of epithelium that require corneal limbal stem cell proliferation. Cytokines and trophic factors from corneal nerves, the tear film, the conjunctiva, conjunctival vessels, the endothelium, and the anterior chamber may have important modulating effects on corneal epithelial and stromal healing responses and, thus, corneal ulceration.
Frequency:
Mortality/Morbidity: Corneal scarring, decreased vision, neovascularization, perforation, and blindness are associated with this condition. Sex: Because of an increased incidence of injuries, this condition may be seen more frequently in males than females.
History:
Physical:
Causes: A thorough history and physical examination should allow a clinician to narrow down the differential diagnosis.
Corneal Abrasion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lab Studies:
Procedures:
Medical Care: Individual treatment should be tailored toward the coconspirators that are identified by the history and physical examination. Again, the importance of first excluding infectious etiologies is paramount. Once identified, each contributing factor needs to be treated appropriately. All toxic drops should be eliminated if medicamentosa is suspected. Lagophthalmos should be treated with copious lubrication, with taping for variable amounts of time, beginning with sleeping hours. Tarsorrhaphy is indicated if previous method fails. Patients with sicca need copious lubrication and punctal plugs. Evaluate these patients for systemic rheumatologic disease if suspected by clinical history or examination. If immune disease is suspected, systemic immunomodulatory therapy may be necessary. Treatment modalities are outlined below.
Surgical Care: See Medical Care for possible surgical treatments. Consultations:
As discussed in Medical Care, a number of medications for sterile corneal ulcers refractory to conventional treatment are currently being investigated with respect to their clinical efficacy (eg, fibronectin, vitamin A, ascorbic acid, serum-derived tears, metalloproteinase inhibitors, neurotrophic growth factor). Therefore, standard dosing, indications, treatment regimens, and contraindications with respect to these medications are not available. The authors recommend that interested physicians directly contact clinical investigators for specific treatment regimens currently employed in treatment trials. Antibiotics often are used prophylactically in treating patients with sterile corneal ulcerations. Specific dosing and medication information on topical antibiotics are not included in this article. Immunomodulatory treatment regimens are complex,
and elaborating on medication dosing and treatment
regimens for specific rheumatologic diseases is
beyond the scope of this article. Drug Category: Ophthalmic corticosteroids -- Minimize the activity of inflammatory cells and formation of granulomas. Used in symptomatic patients and commonly provides symptomatic improvement.
Further Outpatient Care:
Deterrence/Prevention:
Complications:
Prognosis:
Medical/Legal Pitfalls:
Special Concerns:
Central Sterile Corneal Ulceration excerpt © Copyright 2002, eMedicine.com, Inc. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
I promise to answer your message -- click here to send me a personal message
|
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.
You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:24 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.